Description of parallel and sequential configurations for concurrent therapeutic plasma exchange and continuous kidney replacement therapy in adults
© 2020 Wiley Periodicals LLC..
Therapeutic plasma exchange (TPE) and continuous kidney replacement therapy (CKRT) are extracorporeal therapeutic procedures often implemented in management of patients. Critically ill patients may be afflicted with disease processes that require both TPE and CKRT. Performing TPE discontinuous with CKRT is technically easier, however, it disrupts CKRT and may compromise with CKRT efficiency or hemofilter life. Concurrent TPE with CKRT offers several advantages including simultaneous control of disease process and correction of electrolyte, fluid, and acid-base disturbances that may accompany TPE. Additionally, TPE may be performed by either centrifugation method or membrane plasma separation method. The technical specifications of these methods may influence the methodology of concurrent connections. This report describes and reviews two different approaches to circuit arrangements when establishing concurrent TPE and CKRT.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:36 |
---|---|
Enthalten in: |
Journal of clinical apheresis - 36(2021), 1 vom: 01. Feb., Seite 211-218 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kaushik, Manish [VerfasserIn] |
---|
Links: |
---|
Themen: |
Acute liver failure |
---|
Anmerkungen: |
Date Completed 08.11.2021 Date Revised 08.11.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/jca.21854 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM317871420 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM317871420 | ||
003 | DE-627 | ||
005 | 20231225164154.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/jca.21854 |2 doi | |
028 | 5 | 2 | |a pubmed24n1059.xml |
035 | |a (DE-627)NLM317871420 | ||
035 | |a (NLM)33220117 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kaushik, Manish |e verfasserin |4 aut | |
245 | 1 | 0 | |a Description of parallel and sequential configurations for concurrent therapeutic plasma exchange and continuous kidney replacement therapy in adults |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.11.2021 | ||
500 | |a Date Revised 08.11.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2020 Wiley Periodicals LLC. | ||
520 | |a Therapeutic plasma exchange (TPE) and continuous kidney replacement therapy (CKRT) are extracorporeal therapeutic procedures often implemented in management of patients. Critically ill patients may be afflicted with disease processes that require both TPE and CKRT. Performing TPE discontinuous with CKRT is technically easier, however, it disrupts CKRT and may compromise with CKRT efficiency or hemofilter life. Concurrent TPE with CKRT offers several advantages including simultaneous control of disease process and correction of electrolyte, fluid, and acid-base disturbances that may accompany TPE. Additionally, TPE may be performed by either centrifugation method or membrane plasma separation method. The technical specifications of these methods may influence the methodology of concurrent connections. This report describes and reviews two different approaches to circuit arrangements when establishing concurrent TPE and CKRT | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a acute liver failure | |
650 | 4 | |a concurrent | |
650 | 4 | |a continuous kidney replacement therapy | |
650 | 4 | |a plasma exchange | |
650 | 4 | |a tandem | |
650 | 4 | |a thrombotic thrombocytopenic purpura | |
700 | 1 | |a Liew, Zhong Hong |e verfasserin |4 aut | |
700 | 1 | |a Sewa, Duu-Wen |e verfasserin |4 aut | |
700 | 1 | |a Phua, Ghee Chee |e verfasserin |4 aut | |
700 | 1 | |a Cao, Ling |e verfasserin |4 aut | |
700 | 1 | |a Krishnamoorthy, Thinesh Lee |e verfasserin |4 aut | |
700 | 1 | |a Ng, Shin Yi |e verfasserin |4 aut | |
700 | 1 | |a Lim, Amy Ee Lin |e verfasserin |4 aut | |
700 | 1 | |a Ng, Li Choo |e verfasserin |4 aut | |
700 | 1 | |a Koniman, Riece |e verfasserin |4 aut | |
700 | 1 | |a Teo, Su Hooi |e verfasserin |4 aut | |
700 | 1 | |a Tan, Han Khim |e verfasserin |4 aut | |
700 | 0 | |a S.I.N:G.A.P.O.R.E Initiative (Science In Nephrology: Growth And Progress Of Research & Education Initiative) |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of clinical apheresis |d 1993 |g 36(2021), 1 vom: 01. Feb., Seite 211-218 |w (DE-627)NLM012676969 |x 0733-2459 |7 nnns |
773 | 1 | 8 | |g volume:36 |g year:2021 |g number:1 |g day:01 |g month:02 |g pages:211-218 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/jca.21854 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 36 |j 2021 |e 1 |b 01 |c 02 |h 211-218 |